The Patent Finder
US

High Refractive-Index, Hydrophilic Monomers and Polymers, and Ophthalmic Devices Comprising Such Polymers

US 7,781,496 Lapsed on the fee record
OverviewFamilyAssignmentsSources & methods

Lapsed Aug 24, 2022 on the fee record · Low confidence

Third maintenance fee unpaid; grace period ended.

No current holder resolved from the recorded chain.
Filed Nov 19, 2008 as application 12/273,624 · Granted Aug 24, 2010
Base term, 20 years from filing, plus 143 days of patent term adjustment (USPTO delay)
Today
Lapsed Aug 24, 2022
2005 2026
Clock starts
May 27, 2005
No longer in force
Aug 24, 2022
Granted
Aug 24, 2010
Term would have run to
Oct 17, 2025
base term patent term adjustment after the term ends fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
143
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

Its term would have run to Oct 17, 2025: its 20-year base term plus 143 days of term adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts May 27, 2005, when application 11/139,276, the earliest non-provisional in its chain, was filed (this one was filed Nov 19, 2008); a parent in its chain could not be resolved (the next row)May 27, 2025High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustment+143 days, USPTO patent term adjustment recordOct 17, 2025High confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidlapsed Aug 24, 2022High confidence
Computed term endThe steps above, in orderAug 24, 2022Low confidence

This family

US 7,495,061In force
Dec 2026
Dec 2026
Application PCT/US2006/020020PCT application
no patent term
no patent term
US 7,781,496this patent
Aug 2022
Aug 2022
3 of 4 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

The 40 most recent of 98 recorded documents are shown; the 58 earliest are not. Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentBausch Health US, LLCRelease of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentBausch Health, Canada Inc. / Sante Bausch, Canada Inc.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentICN Polfa Rzeszow Spolka Akcyjna (A/K/A ICN Polfa Rzeszow S.A.)Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentOrapharma, Inc.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentPrzedsiebiorstwo Farmaceutyczne Jelfa Spolka Akcyjna (A/K/A Przedsiebiorstwo Farmaceutyczne Jelfa S.A.)Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentSolta Medical Dutch Holdings B.V.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentV-Bac Holding Corp.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral AgentVRX Holdco LLCRelease of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral Agent1261229 B.C. Ltd.Release of Security Interest
Apr 8, 2025
reel/frame not recorded
Barclays Bank PLC, as Collateral Agent1530065 B.C. Ltd.Release of Security Interest
Aug 14, 2025
Reel 72469, frame 91
Citibank, N.A., as Resigning AgentJPMorgan Chase Bank, N.A., as Successor AgentAssignment of Security Interest in Patents Previously Recorded at Reel/Frame (059913/0548)
Nov 20, 2025
Reel 73637, frame 1
The Bank of New York Mellon, as Notes Collateral AgentAton Pharma, Inc.; Bausch & Lomb Incorporated; Bausch & Lomb Pharma Holdings Corp.; Commonwealth Laboratories, LLC; Dow Pharmaceutical Sciences, Inc.; Ecr Pharmaceuticals Co., Inc.; Laboratoire Chauvin S.A.S.; Medicis Pharmaceutical Corporation; Onpharma Inc.; Orapharma, Inc.; Precision Dermatology, Inc.; Salix Pharmaceuticals, Ltd.; Salix Pharmaceuticals, Inc.; Santarus, Inc.; Solta Medical, Inc.; Synergetics USA, Inc.; Technolas Perfect Vision GmbH; Valeant Canada LP; Valeant Pharmaceuticals International; Valeant Pharmaceuticals International, Inc.; Valeant Pharmaceuticals North America LLC; Wirra IP Pty Limited; Valeant Pharma Poland SP. Z O.O.; Valeant Pharmaceuticals Luxembourg S.A R.L.; Valeant Pharmaceuticals Ireland LimitedRelease of Security Interest
Nov 20, 2025
Reel 73654, frame 242
The Bank of New York Mellon, as Notes Collateral AgentBausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.; Bausch Health Americas, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentAton Pharma, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch & Lomb IncorporatedRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch & Lomb Pharma Holdings Corp.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentCommonwealth Laboratories, LLCRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentDow Pharmaceutical Sciences, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentEcr Pharmaceuticals Co., Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentLaboratoire Chauvin S.A.S.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentMedicis Pharmaceutical CorporationRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentOnpharma Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentOrapharma, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentPrecision Dermatology, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSalix Pharmaceuticals, Ltd.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSalix Pharmaceuticals, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSantarus, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSolta Medical, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSynergetics USA, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentTechnolas Perfect Vision GmbHRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentValeant Canada LPRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentValeant Pharmaceuticals InternationalRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentValeant Pharmaceuticals International, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentValeant Pharmaceuticals North America LLCRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentWirra IP Pty LimitedRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentValeant Pharma Poland SP. Z O.O.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentValeant Pharmaceuticals Luxembourg S.A R.L.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentValeant Pharmaceuticals Ireland LimitedRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health Americas, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health US, LLCRelease of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited